Understanding how FFA4 affects insulin and glucagon secretion in diabetes
FFA4 regulation of pancreatic islet function
This study is looking at how a specific receptor in the pancreas helps control the hormones that manage blood sugar, which could lead to new treatments for diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11062539 on NIH RePORTER |
What this research studies
This research investigates the role of the long chain fatty acid receptor 4 (FFA4) in regulating insulin and glucagon secretion from pancreatic islet cells, which is crucial for managing diabetes. The study aims to identify how FFA4 influences the communication between different cell types within the islets, particularly focusing on its effects on d cells and their interaction with insulin-producing b cells. By exploring these mechanisms, the research seeks to uncover new therapeutic targets that could lead to innovative treatments for diabetes.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are living with type 2 diabetes or pre-diabetes.
Not a fit: Patients with type 1 diabetes or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new diabetes treatments that improve insulin secretion and overall blood sugar control.
How similar studies have performed: Previous research has shown promise in targeting similar pathways for diabetes treatment, indicating potential for success in this approach.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Huising, Mark O. — University of California at Davis
- Study coordinator: Huising, Mark O.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.